{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:34:50Z","timestamp":1789662890101,"version":"4.0.1"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Agent Orange (AO), a toxic herbicide mixture contaminated with carcinogenic dioxin, was widely used during the Vietnam War. Although epidemiologic evidence suggests AO exposure is associated with increased lymphoid malignant neoplasm risk, the details of this association and its potential interaction with genetic factors remain unclear.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate (1) whether AO exposure was associated with increased risk of lymphoid malignant neoplasms, (2) associations of polygenic risk scores (PRSs) in specific lymphoid malignant neoplasms, and (3) whether there was a genetic component \u00d7 exposure interaction associated with increased risk of developing lymphoid malignant neoplasms.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>A case-control study of 255\u202f155 US veterans enrolled in the Veterans Affairs Million Veteran Program was conducted with available genotype, AO exposure information, and lymphoid malignant neoplasm diagnosis from January 1, 1965, through June 11, 2024.<\/jats:p><\/jats:sec>Exposures<\/jats:title>AO exposure status (based on self-reported survey) and PRS derived from genome-wide association studies of lymphoid malignant neoplasms.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Risk of developing lymphoid malignant neoplasm subtypes: chronic lymphocytic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, and multiple myeloma.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 255\u202f155 non-Hispanic White veterans (median [IQR] age, 67 [61-74] years; 235\u202f895 [92.5%] male) with both PRS and AO data were included in this study. AO exposure was associated with an increased risk of chronic lymphocytic leukemia (odds ratio [OR], 1.61; 95% CI, 1.40-1.84), diffuse large B-cell lymphoma (OR, 1.26; 95% CI, 1.03-1.53), follicular lymphoma (OR, 1.71; 95% CI, 1.39-2.11), and multiple myeloma (OR, 1.58; 95% CI, 1.35-1.86). Similarly, PRS was associated with all subtypes: chronic lymphocytic leukemia (OR, 1.81; 95% CI, 1.70-1.93), diffuse large B-cell lymphoma (OR, 1.12; 95% CI, 1.02-1.21), follicular lymphoma (OR, 1.33; 95% CI, 1.21-1.47), marginal zone lymphoma (OR, 1.17; 95% CI, 1.04-1.32), and multiple myeloma (OR, 1.41; 95% CI, 1.31-1.52). No significant PRS\u2009\u00d7\u2009AO interactions were observed.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>To date, this is the largest case-control study of AO exposure and risk of lymphoid malignant neoplasm subtypes and the only study to investigate an AO\u2009\u00d7\u2009gene association with risk. The study found independent associations of both genetic predisposition and AO exposure on several lymphoid malignant neoplasm subtypes.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.26787","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:00:31Z","timestamp":1755097231000},"page":"e2526787","source":"Crossref","is-referenced-by-count":4,"title":["Polygenic Risk, Agent Orange Exposure, and Lymphoid Neoplasms in the Veterans Affairs Million Veteran Program"],"prefix":"10.1001","volume":"8","author":[{"given":"Xueyi","family":"Teng","sequence":"first","affiliation":[{"name":"Department of Biological Chemistry, School of Medicine, University of California, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Y.","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Joe C. Wen School of Population & Public Health, University of California, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Gupta","sequence":"additional","affiliation":[{"name":"Tibor Rubin Veterans Affairs Medical Center, Long Beach, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, School of Medicine, University of California, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Cozen","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, University of California, Irvine"},{"name":"Chao Family Comprehensive Cancer Center, University of California, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ma","sequence":"additional","affiliation":[{"name":"Tibor Rubin Veterans Affairs Medical Center, Long Beach, California"},{"name":"Division of Hematology\/Oncology, Department of Medicine, University of California, Irvine"},{"name":"Chao Family Comprehensive Cancer Center, University of California, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"6","key":"zoi250754r1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.7205\/MILMED-D-11-00434","article-title":"Cancer incidence among patients of the U.S. Veterans Affairs Health Care System.","volume":"177","author":"Zullig","year":"2012","journal-title":"Mil Med"},{"issue":"5","key":"zoi250754r2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/00043764-198805000-00007","article-title":"Proportionate mortality study of US Army and US Marine Corps veterans of the Vietnam War.","volume":"30","author":"Breslin","year":"1988","journal-title":"J Occup Med"},{"issue":"12","key":"zoi250754r4","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S1470-2045(09)70358-4","article-title":"A review of human carcinogens\u2013part F: chemical agents and related occupations.","volume":"10","author":"Baan","year":"2009","journal-title":"Lancet Oncol"},{"key":"zoi250754r5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tox.2016.10.007","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) role in hematopoiesis and in hematologic diseases: a critical review.","volume":"374","author":"Fracchiolla","year":"2016","journal-title":"Toxicology"},{"issue":"10","key":"zoi250754r6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/ng.2733","article-title":"Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.","volume":"45","author":"Chubb","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"zoi250754r7","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1182\/blood-2010-09-308205","article-title":"Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.","volume":"117","author":"Slager","year":"2011","journal-title":"Blood"},{"issue":"4","key":"zoi250754r8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ajhg.2014.09.004","article-title":"Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.","volume":"95","author":"Skibola","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"11","key":"zoi250754r9","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/ng.3105","article-title":"Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.","volume":"46","author":"Cerhan","year":"2014","journal-title":"Nat Genet"},{"key":"zoi250754r10","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1038\/ncomms6751","article-title":"A genome-wide association study of marginal zone lymphoma shows association to the HLA region.","volume":"6","author":"Vijai","year":"2015","journal-title":"Nat Commun"},{"issue":"14","key":"zoi250754r11","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1158\/0008-5472.CAN-17-2900","article-title":"HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes.","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res"},{"issue":"12","key":"zoi250754r12","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1038\/s41375-022-01711-0","article-title":"Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.","volume":"36","author":"Berndt","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"zoi250754r13","doi-asserted-by":"publisher","first-page":"910","DOI":"10.21037\/tlcr-21-698","article-title":"Are polygenic risk scores ready for the cancer clinic? a perspective.","volume":"11","author":"Klein","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"zoi250754r14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jclinepi.2015.09.016","article-title":"Million Veteran Program: a mega-biobank to study genetic influences on health and disease.","volume":"70","author":"Gaziano","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"zoi250754r15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41588-021-00783-5","article-title":"The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation.","volume":"53","author":"Lambert","year":"2021","journal-title":"Nat Genet"},{"issue":"4","key":"zoi250754r16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ajhg.2020.03.004","article-title":"Genotyping array design and data quality control in the Million Veteran Program.","volume":"106","author":"Hunter-Zinck","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"4","key":"zoi250754r17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ajhg.2020.03.004","article-title":"Genotyping array design and data quality control in the Million Veteran Program.","volume":"106","author":"Hunter-Zinck","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"9","key":"zoi250754r18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/ng.3623","article-title":"Identification of 15 genetic loci associated with risk of major depression in individuals of European descent.","volume":"48","author":"Hyde","year":"2016","journal-title":"Nat Genet"},{"issue":"7571","key":"zoi250754r19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation.","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"issue":"1","key":"zoi250754r20","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1038\/s41467-018-04989-w","article-title":"Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.","volume":"9","author":"Went","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"zoi250754r21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1182\/bloodadvances.2019000491","article-title":"A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.","volume":"4","author":"Du","year":"2020","journal-title":"Blood Adv"},{"key":"zoi250754r22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets.","volume":"4","author":"Chang","year":"2015","journal-title":"Gigascience"},{"issue":"12","key":"zoi250754r23","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv279","article-title":"Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types.","volume":"107","author":"Sampson","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"zoi250754r24","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/archinte.1990.00390230033005","article-title":"The association of selected cancers with service in the US military in Vietnam, I: non-Hodgkin\u2019s lymphoma.","volume":"150","author":"The Selected Cancers Cooperative Study Group","year":"1990","journal-title":"Arch Intern Med"},{"issue":"4","key":"zoi250754r25","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1182\/bloodadvances.2023011999","article-title":"Survival in Agent Orange exposed and unexposed Vietnam-era veterans who were diagnosed with lymphoid malignancies.","volume":"8","author":"Ma","year":"2024","journal-title":"Blood Adv"},{"issue":"48","key":"zoi250754r26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","article-title":"Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.","volume":"2014","author":"Morton","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"13","key":"zoi250754r27","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1182\/blood-2008-01-133587","article-title":"Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.","volume":"112","author":"Morton","year":"2008","journal-title":"Blood"},{"issue":"1","key":"zoi250754r28","first-page":"11","article-title":"Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma.","volume":"21","author":"Ng","year":"2010","journal-title":"Cancer Causes Control"},{"key":"zoi250754r3","year":"2018"},{"key":"zoi250754r29","volume-title":"Veterans and Agent Orange: Update 2002","author":"Institute of Medicine (US) Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides","year":"2003"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2837481\/teng_2025_oi_250754_1757523108.66231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:00:43Z","timestamp":1758034843000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2837481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.26787","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}